Hvad er åbningstiderne?

Mandag 09:00 - 16:00 Tirsdag 09:00 - 16:00 Onsdag 09:00 - 16:00 Torsdag 09:00 - 16:00 Fredag 09:00 - 16:00

CHIP, Centre of Excellence for Health, Immunity and Infections

Hjem
Danmark
Copenhagen
CHIP, Centre of Excellence for Health, Immunity and Infections

CHIP produces internationally recognised research aimed at people with affected immune systems on how best to improve their health and extend life.

03/06/2025

🎓🎉We are proud to announce that on Wednesday, May 28th, 2025, Tomas Jensen successfully defended his PhD thesis:

🧬 “Immunovirological dynamics in patients hospitalized with COVID-19”

Please join us in congratulating Dr. Jensen on this remarkable milestone! 👏🥳

14/05/2025

PARTNER2-STUDIET VINDER VIGTIGSTE VIDEN DELT 🏆

I fredags markerede vi AIDS-Fondets 40 års jubilæum ved at uddele priser til tre personer, som har bidraget med vigtig viden, politisk tæft og kampklare kjoler. De tre priser tager udgangspunkt i tre vendepunkter i kampen mod hiv, som i løbet af de 40 år har haft betydning for mennesker, der lever med hiv, deres partnere og nære.

Prisen for Vigtigste Viden Delt gik til PARTNER2-studiet, der er det danskledede studie, som en gang for alle har slået fast, at velbehandlet hiv ikke smitter. I en del år var det almindeligt kendt blandt læger, at der nok ikke var nogen synderlig risiko for at overføre hiv, hvis man var hiv-positiv og velbehandlet.

Det var sandsynligt, at det var sådan, men det var ikke videnskabeligt bevist, så det var ikke noget, man kunne sige med sikkerhed. Det ville være en enorm videnskabelig opgave at bevise. Man skulle bevise, at noget aldrig ville kunne ske. Det var den opgave forskerne bag PARTNER2-studiet tog på sig.

Studiet har fulgt knapt 1000 par med homoseksuelle mænd i 14 europæiske lande, hvor den ene var velbehandlet hiv-positiv, og den anden ikke havde hiv. I de knapt otte år studiet varede, havde parrene analsex uden kondom næsten 77.000 gange – uden nogen blev smittet.

PARTNER2-studiet er solid forskning, som har vakt anerkendelse blandt forskningskolleger verden over. Det er formidlet, så ingen længere er i tvivl – velbehandlet hiv smitter ikke. 💯

Resultatet af PARTNER2-studiet blev offentliggjort i 2018, og det har haft kæmpe betydning for hiv-positive verden over, for deres partnere, og for det homo-miljø, hvor hiv har fyldt så meget. PARTNER2-studiet fortjener prisen Bedste Viden Delt.

Prisen blev modtaget af sygeplejerske Tina Bruun, der også er projektleder på CHIP, som er det internationale forskningssamarbejde, der står bag PARTNER2-studiet. ❤️

📸: Mio Voisin

29/04/2025

We would like to congratulate Nadine Jaschinski for successfully defending her PhD thesis on Cardiovascular Disease Risk Factors, Preventive Measures, and Incidence Trends in People with HIV.

21/02/2025

𝗧𝗮𝗹𝗸𝗶𝗻𝗴 𝗮𝗯𝗼𝘂𝘁 𝘀𝗲𝘅 𝗰𝗮𝗻 𝗯𝗲 𝗮𝘄𝗸𝘄𝗮𝗿𝗱, 𝗯𝘂𝘁 𝗶𝘁 𝗱𝗼𝗲𝘀𝗻'𝘁 𝗵𝗮𝘃𝗲 𝘁𝗼 𝗯𝗲!

Join our webinar on 2 April and learn how to connect with young people about awareness in a way that actually works.

We'll discuss the latest trends in communication and explore what messages resonate with today's youth.

Register: https://bit.ly/4hInxkM

20/02/2025

Want to make a REAL difference in STI prevention among MSM?

𝗝𝗼𝗶𝗻 𝗼𝘂𝗿 𝘄𝗲𝗯𝗶𝗻𝗮𝗿 𝗼𝗻 𝟮𝟲 𝗠𝗮𝗿𝗰𝗵 𝗮𝗻𝗱 𝗹𝗲𝗮𝗿𝗻 𝗵𝗼𝘄.

We'll explore the power of partnerships between public health, community organizations, and healthcare providers.

This webinar, brought to you by European Centre for Disease Prevention and Control - ECDC, European AIDS Clinical Society, and CHIP, Centre of Excellence for Health, Immunity and Infections, will help you take action in your own community.

Register: https://bit.ly/4gMCfpB

20/12/2024

Registrations for the Innovation in Tuberculosis Workshops 2025: Research Perspectives for Europe (22-23 May 2025), co-organized by CHIP, WHO Regional Office for Europe, and ECDC, are now open. Interested researchers, clinicians, and epidemiologists are invited to submit their applications at https://eurotb.net/m/innovate2endtb by 14 February 2025. A limited number of scholarships is available.
European Centre for Disease Prevention and Control - ECDC
WHO Regional Office for Europe

20/12/2024

🎉 Congratulations to Erich Tusch on successfully defending his PhD thesis 🥳 on "Causes of Death and Mortality Risk Factors Among People Living with HIV: Recent Changes and Unique Risks"!

Let’s all celebrate Erich's success together! 👏

12/11/2024

Yet another inspiring day at
We are honoured to have Lene Ryom join the panellists of the Clinical Case Study Session

11/11/2024

A great session on "Managing Cardiometabolic Risk in HIV: The Role of Old and New Drugs" and we are excited to have Nadine Jaschinski represent RESPOND (International Cohort Consortium of Infectious Disease) at the panel discussion.

11/11/2024

Our team is excited to present our posters at the
Find them displayed the exhibition area.
The poster numbers are: P011, P272, P307, P334
We want to wish everyone an inspiring and productive time at the 2024 HIV Glasgow Congress.

07/11/2024

We are honored to receive a chance to present 4 Scientific Posters at the 2024 Congress.

Come find our posters in the exhibition area⤵️

19/09/2024

Har du erfaring med at koordinere kliniske forsøg?
Vi leder efter en klinisk projektkoordinator (Clinical Research Associate) til et 1-årigt barselsvikariat hos Center of Excellence for Health, Immunity and Infections (CHIP) med opstart så hurtigt som muligt.
Læs mere og ansøg senest den 8. oktober 2024 her👉 https://t.ly/-wBML

Adresse

Øster Allé 56
Copenhagen
2100

Åbningstider

Mandag	09:00 - 16:00
Tirsdag	09:00 - 16:00
Onsdag	09:00 - 16:00
Torsdag	09:00 - 16:00
Fredag	09:00 - 16:00

Internet side

http://www.chip.dk/

Underretninger

Vær den første til at vide, og lad os sende dig en email, når CHIP, Centre of Excellence for Health, Immunity and Infections sender nyheder og tilbud. Din e-mail-adresse vil ikke blive brugt til andre formål, og du kan til enhver tid afmelde dig.

Genveje

Vil du plassere din praksis på toppen av Klinik-listen i Copenhagen?

Del

Type

Medicinsk forskningscenter

The Mission of CHIP

CHIP (Centre of Excellence for Health, Immunity and Infections) produces internationally recognised research aimed at people with affected immune systems on how best to improve their health and extend life.

History

For the last two decades, CHIP has focused primarily on sections of the population having immune dysfunction such as people living with HIV. More recently, this has been expanded to incorporate other patient categories such as organ transplant recipients, cancer patients, patients with autoimmune disease and other groups with increased vulnerability to infectious diseases.

In 2014, CHIP was re-named as a Centre of Excellence by the Capital region of Denmark in addition to receiving a 10-year Danish National Research Foundation Centre of Excellence grant for studying Personalized Medicine of Infectious Complications of Immune Deficiency (PERSIMUNE, www.persimune.dk).